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Rhomboid family member 2 regulates cytoskeletal
stress-associated Keratin 16
Thiviyani Maruthappu1,*, Anissa Chikh1,*, Benjamin Fell1, Paul J. Delaney1, Matthew A. Brooke1, Clemence Levet2,
Angela Moncada-Pazos2, Akemi Ishida-Yamamoto3, Diana Blaydon1, Ahmad Waseem4, Irene M. Leigh5,
Matthew Freeman2 & David P. Kelsell1
Keratin 16 (K16) is a cytoskeletal scaffolding protein highly expressed at pressure-bearing
sites of the mammalian footpad. It can be induced in hyperproliferative states such as wound
healing, inﬂammation and cancer. Here we show that the inactive rhomboid protease RHBDF2
(iRHOM2) regulates thickening of the footpad epidermis through its interaction with K16.
K16 expression is absent in the thinned footpads of irhom2 / mice compared with
irhom2þ /þmice, due to reduced keratinocyte proliferation. Gain-of-function mutations in
iRHOM2 underlie Tylosis with oesophageal cancer (TOC), characterized by palmoplantar
thickening, upregulate K16 with robust downregulation of its type II keratin binding partner,
K6. By orchestrating the remodelling and turnover of K16, and uncoupling it from K6, iRHOM2
regulates the epithelial response to physical stress. These ﬁndings contribute to our under-
standing of the molecular mechanisms underlying hyperproliferation of the palmoplantar
epidermis in both physiological and disease states, and how this ‘stress’ keratin is regulated.
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T
he ridged skin of the palms and soles (palmoplantar sites)
in mammals is uniquely adapted to withstand remarkable
physical stress1–4. The actual physical resilience of the
palmoplantar epidermis is thought to be predominantly due to an
abundance of cytoskeletal scaffolding proteins known as keratin
intermediate ﬁlaments5. Keratins constitute up to 85% of the
protein content of differentiated epithelial cells and provide both
ﬂexibility and strength by forming a framework within the
cytoplasm6. Over 50 Keratin isotypes are expressed in stratiﬁed
and pseudostratiﬁed epithelia7; however, their precise expression
pattern is both site and situation speciﬁc8,9. Keratins are also
expressed in a pairwise manner, with a type I keratin (acidic,
keratins 9–20) paired with its speciﬁc type II partner (basic,
keratins 1–8), for example, K6/K16 and K1/K10 (refs 8,10).
Speciﬁc pairs initiate heterodimerization through their coiled-coil
domains, forming 10 nm ﬁlaments, which self-assemble to form
the keratin ﬁlament network11,12.
Unlike inter-follicular skin, the ridged skin of the palms and
soles is characterized by the constitutive expression of Keratins 6,
16, 17 and uniquely, Keratin 9 (K9)1,5. In addition to its high
expression in the palmoplantar epidermis, K16 can be induced in
hyperproliferative states such as during wound healing2,3 and
inﬂammatory skin diseases13. On regeneration, epithelial cells at
the wound edge deviate from their normal expression pattern,
downregulating K10 and inducing K16 expression within 6 h of
injury2,3. K16 is also a biomarker of several cancers particularly
squamous cell carcinomas, including those originating from
cervical, oesophageal and nasopharyngeal epithelia9,14,15. The
tightly restricted expression pattern of K16 supports the notion
that this particular keratin bears unique properties; however, how
the dynamic regulation of K16 occurs in response to physiological
and cellular stress remains poorly understood.
Several genetic skin disorders show a predilection for
palmoplantar sites16. For example, germline dominant or
recessive mutations in K16 in both humans17,18 and mice19
lead to hyperproliferative thickening of the palms and soles
termed palmoplantar keratoderma (PPK). In humans, PPKs
arising from dominantly inherited mutations in K16 are called
pachyonychia congenita. This monogenic disorder is associated
with painful thickening of the palmoplantar epidermis on weight
bearing17. Other PPKs can be caused by inherited defects in
non-keratin genes16. One example is Tylosis with oesophageal
cancer (TOC, OMIM:148500)20. TOC is inherited as an
autosomal dominant trait and affected individuals ﬁrst present
with PPK in childhood21. Moreover, they carry a 495% lifetime
risk of developing oesophageal squamous cell carcinoma by 65
years of age21. Gain-of-function mutations in the gene encoding
the inactive rhomboid protease RHBDF2 (iRHOM2) are the
underlying cause of this syndrome4. In mammalian myeloid and
epithelial cells, iRHOM2 promotes the maturation and trafﬁcking
of ADAM17 (a disintegrin and metalloproteinase-17, or tumour
necrosis factor-a (TNFa)-converting enzyme) in the endoplasmic
reticulum and Golgi22. Activated ADAM17 then transits to the
plasma membrane where it is able to cleave its substrates
including TNFa, interleukin-6R and epidermal growth factor
receptor family ligands23,24. In TOC-derived keratinocytes,
iRHOM2 mutations lead to high levels of constitutive ADAM17
activity with elevated ectodomain shedding of many of its
substrates23. TOC keratinocytes also show increased rates of
proliferation and rapid migration in monolayer scratch-wound
assays when compared with control keratinocytes4. These features
suggest that TOC keratinocytes exhibit features resembling a state
of constitutive wound healing. Furthermore, Phorbol
12-myristate 13-acetate (PMA)-stimulated peripheral blood
mononuclear cells (PBMCs) from TOC patients also have
increased TNFa release compared with control PBMCs23. In
contrast, PBMCs/macrophages from irhom2 / mice have
impaired ADAM17 maturation and, consequently, TNFa
shedding from these cells is almost entirely abolished in
response to bacterial stressors22,25.
In this study, we identify iRHOM2 as a novel regulator of K16
in humans and mice, with important implications for PPKs,
wound healing, inﬂammatory skin disease and cancers. We
demonstrate for the ﬁrst time that iRHOM2 binds to K16, and
that this interaction is increased in TOC keratinocytes, where it is
associated with robust downregulation of K16’s binding partner
K6. In humans and mice, iRHOM2 loss results in dampened
proliferation and reduced K16 expression, and in mice this leads
to thinning of epidermis in the footpad. These ﬁndings highlight
a novel and fundamental role for iRHOM2 in regulating the
epithelial response to mechanical stress.
Results
iRHOM2 / mice paws reveal a thinner epidermis. To eluci-
date the role of iRHOM2 in the skin, we examined irhom2 /
mice22,25. Although these mice were reported to be physically
similar to irhom2þ /þ mice20,23, re-assessment revealed a striking
difference in the paws of adult irhom2 / mice. Examination of
their forepaws and hind paws revealed diminution of the stress-
bearing footpads and also showed pallor and translucency,
lacking the normal thickening and hyperpigmentation of the
footpads seen in irhom2þ /þ littermates (Fig. 1a and Supple-
mentary Fig. 1a). Microscopic examination of haematoxylin
and eosin-stained skin sections of the fore and hind paws of
irhom2 / mice showed thinning of the epidermis (Fig. 1b and
Supplementary Fig. 1a). Quantiﬁcation of epidermal thickness
demonstrated that irhom2 / mice footpads were signiﬁcantly
thinner than irhom2þ /þ (Fig. 1c). However, there was no
signiﬁcant difference in the thickness of their back skin. As
keratins comprise a major component of the footpad epidermis
and are known to be altered in palmoplanter keratodermas16, we
performed immunohistochemical staining for the palmoplantar-
expressed keratins; K6, K16 and K9. Surprisingly, this revealed
diminished K16 expression in irhom2 / throughout the
footpad epidermis compared with irhom2þ /þ controls (Fig. 1d
and Supplementary Fig. 1d), whereas the expression of K9 was
comparable (Fig. 1e and Supplementary Fig. 1e). K6, the
predominant type II binding partner of K16 however appeared
to be upregulated compared with irhom2þ /þ (Fig. 1f and
Supplementary Fig. 1f). The irhom2 / mouse footpad
phenotype directly contrasts what is observed in TOC plantar
skin, which exhibits marked thickening and callous formation at
sites of pressure (Fig. 1g). Consistent with the opposing skin
phenotypes, the expression pattern of keratins was also reversed
in TOC skin compared with irhom2 / mice, with increased
K16 expression in lesional interfollicular (non-palm) epidermis
(Fig. 1h). These ﬁndings implicate iRHOM2 in determining
footpad thickness and K16 expression in humans and mice.
K16 is a novel interacting binding partner of iRHOM2. To
decipher how iRHOM2 might regulate the opposing cutaneous
phenotypes in mice and men, and in particular the differences in
K16 expression, a yeast two-hybrid screen was performed using
iRHOM2 as bait (aa1–403) in a three-dimensional (3D) recon-
stituted skin library. The cytoplasmic amino-terminus domain of
iRHOM2 was used as bait in the screen, because all described
TOC-causing mutations (p.Ile186Thr, p.Asp188Ans and
p.Pro189Leu) occur within four residues of this highly conserved
region unique to the iRHOMs4,26. This screen uncovered K16 as a
highly plausible interacting protein (Supplementary Fig. 1g).
Immunocytochemistry revealed partial colocalisation between
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green ﬂuorescent protein (GFP)-tagged iRHOM2 and
endogenous K16 in the human immortalized HaCaT keratino-
cytes cell line (Fig. 2a). To conﬁrm the proposed interaction we
performed co-immunoprecipitation, which showed that
endogenous K16 was able to efﬁciently immunoprecipitate
iRHOM2 (Fig. 2b) in HaCaT cells. To further validate the
results of the yeast two-hybrid screen, the GFP-tagged
N-terminus domain of iRHOM2 or iRHOM2 lacking its
N-terminus were overexpressed in HaCaTs. K16 was able to
immunoprecipitate the N terminus of iRHOM2 but not when this
domain was absent (Fig. 2c). The GFP empty vector control was
negative (Supplementary Fig. 2a). These data conﬁrm the results
of the yeast two-hybrid screen and indicate that iRHOM2 binds
K16, and that this occurs through its N-terminus domain.
As all TOC-causing mutations occur within the N-terminus,
we considered whether this could affect its binding with K16 and
contribute to the high levels of K16 observed in the TOC
epidermis. Immortalized TOC keratinocytes originally derived
from TOC individuals with the dominantly inherited iRHOM2
mutation p.Il2186Thr were used in subsequent experiments4.
Endogenous co-immunoprecipitation using K16 to pull-down
iRHOM2 demonstrated signiﬁcantly increased interaction in
TOC keratinocytes (TOC) compared with similarly immortalized
control keratinocytes (CTRL; Fig. 2d). It has previously been
reported that both iRHOM2 and its rhomboid family member
iRHOM1 can bind ADAM17 (ref. 27); however, K16 did not bind
iRHOM1 in pull-down assays using TOC and CTRL cells
(Fig. 2d and Supplementary Fig. 2b), suggesting that, unlike
ADAM17, the interaction with K16 is iRHOM2 speciﬁc. We also
tested whether iRHOM2 could pull down another abundant
cytoskeletal protein, Vinculin and did not observe an interaction
(Supplementary Fig. 2c).
To further quantify the differences in iRHOM2-K16 binding
between CTRL and TOC cells, proximity ligation assay (PLA) was
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Figure 1 | irhom2 / mice exhibit reduction in epidermal thickness. (a) The hind paws of 16-week-old irhom2 / and irhom2þ /þ littermates
(n¼4 per genotype) were photographed, revealing pallor and diminution of the major stress-bearing paw footpads calluses (black arrowhead) in adult
irhom2 / mice. (b) Haematoxylin and eosin-stained cross-sections of hind-paw footpads showed a reduction in thickness of the epidermis (black line) in
irhom2 / mice. Scale bars, 50mm. (c) Graph depicts the mean thickness of the epidermis of hind paw and back skin from irhom2þ /þ and irhom2 /
mice calculated from ten individual measurements in ﬁve separate cross-sections from each genotype (n¼ 3); error bars denote s.d., *Po0.05 (Student’s
t-test). (d) Immunohistochemistry showing similar K9 expression in paw skin sections. Scale bars, 20mm. (e) Immunohistochemistry demonstrating
reduction of K16 expression in paw skin sections. Scale bars, 20mm. (f) Immunohistochemistry showing upregulation of K6 expression in the hind paw
epidermis of irhom2 / mice compared with irhom2þ /þ . (g) TOC patient feet showing symmetrically thickened skin at pressure-bearing sites (black
arrowheads) on the plantar epidermis. (h) TOC skin demonstrates increased K16 expression throughout the epidermis in comparison with control inter-
follicular skin. Scale bars, 20mm.
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performed. This technique yields a signal when two proteins of
interest are within 40 nm of each other and conﬁrmed
signiﬁcantly increased iRHOM2-K16 signal frequency in TOC
keratinocytes (Fig. 2e). Thus, TOC-associated iRHOM2 muta-
tions appear to increase its binding with K16. As we observed that
K6 expression was increased in the epidermis of irhom2 /
mice, despite a reduction in K16, PLA was also performed
between K6 and K16. This showed a signiﬁcant reduction in the
interaction between the two known binding partners in TOC cells
(Fig. 2f). Taken together, these data indicate that there is a shift in
the balance between the binding partners from K16–K6 to
K16–iRHOM2 in the presence of increased iRHOM2 activity
in TOC.
K16 and K6 are differentially regulated in TOC. K16 is a type I
keratin that forms heterodimers with its major type II binding
partner K6 (ref. 8). Western blotting conﬁrmed a reduction of K6
in TOC keratinocytes compared with CTRL (Fig. 3a). In addition,
immunohistochemistry of TOC skin showed almost absent K6,
despite the presence of abundant K16 (Fig. 3b). Confocal analysis
of TOC cells showed poorly formed K6 ﬁlaments that were
reduced to cytoplasmic aggregates compared with the branch-like
ﬁlament network observed in CTRL keratinocytes (Supple-
mentary Fig. 2d). Furthermore, short hairpin RNA (shRNA)
knockdown of iRHOM2 in TOC cells resulted in restoration of
K6 levels comparable to CTRL (Fig. 3c). Re-expression of K6
was also shown in 3D human skin equivalents derived from
sh-iRHOM2 TOC cells, in contrast to reduced K6 expression in
CTRL 3D cultures, whereas K16 was reduced in both sh-iRHOM2
cell lines (Fig. 3d,e). Intriguingly, quantitative PCR showed that
K6 messenger RNA (mRNA) levels were signiﬁcantly reduced in
TOC cells, where K16 mRNA levels were increased, suggesting
that the regulation of these two keratins also occurs at tran-
scriptional level (Supplementary Fig. 2e). These data imply that
the gain-of-function mutant form of iRHOM2 in TOC is asso-
ciated with increased interaction with K16 and reduced levels of
K6 at both mRNA and protein level, suggesting a reciprocal
regulation of K6 and K16. To explore a potential mechanism for
this, we re-evaluated the yeast two-hybrid screen. The two prey
clone K16 fragments found to interact with the iRHOM2
N-terminus bait share a 143 amino acid overlapping region,
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Figure 2 | The N terminus of iRHOM2 interacts with K16. (a) Confocal microscopy analysis of GFP-tagged iRHOM2 overexpressed in CTRL keratinocytes
showing co-localization with endogenous K16. Pseudocoloured ‘product of the differences from the mean’ (PDM) images, in which each pixel is equal to the
PDM value at that location, are shown with a PDM scale. Scale bar, 20mm. (b) Control (CTRL) keratinocyte lysates were immunoprecipitated with anti-K16
antibody and immunoblotted with anti-iRHOM2 antibody. (c) Left panel: cell extracts from CTRL keratinocytes transfected with a vector expressing NT-
iRHOM2-GFP were immunoprecipitated with anti-K16 antibody and analysed by western blotting with anti-GFP and anti-K16 antibodies. Right panel: cell
extracts from CTRL keratinocytes transfected with a vector expressing HA-tagged iRHOM2 lacking its N terminus (iRHOM2-DNT-HA) were
immunoprecipitated with anti-K16 antibody and analysed by western blotting with anti-HA and anti-K16 antibodies. (d) CTRL and TOC keratinocyte lysates
were immunoprecipitated with anti-K16 antibody and analysed by western blotting with anti-iRHOM1 and anti-iRHOM2 antibody. Graph depicting fold
change of iRHOM2 pull-down by K16 in TOC cells compared with CTRL (n¼ 3); error bars denote s.d., *Po0.05 (Student’s t-test). (e) PLA between
iRHOM2 and K16 analysed by confocal microscopy in CTRL and TOC keratinocytes. Graph represents quantiﬁcation of red ﬂuorescent PLA signals relative
to 4,6-diamidino-2-phenylindole (DAPI). Mean of 3 experiments, each experiment comprising 12 separate images. Error bars denote s.d. *Po0.05
(Student’s t-test). Scale bar, 20mm. (f) PLA between K6 and K16 analysed by confocal microscopy. The graph shows quantiﬁcation of red ﬂuorescent PLA
signals relative to DAPI. Mean of 3 experiments, each experiment comprising 12 separate images. Error bars denote s.d.*Po0.05 (Student’s t-test).
Scale bar, 20mm.
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which corresponds to Coil 1B of K16 (Supplementary Fig. 3a).
Keratins are composed of head and tail domains, as well as
central helical coiled-coiled domains (Coil 1A, 1B 2A and 2B),
each with speciﬁc functions28. The Coil 1B domain plays a role in
heterodimerisation between type I and II keratins29. Increased
binding of iRHOM2 to the coil 1B domain of K16 in TOC could
therefore physically impair dimerization with its binding partner
K6 and potentially contribute to its downregulation. Our data
imply that differential modulation of K16 and K6 expression is
likely to be iRHOM2 dependent.
iRHOM2 regulates the reorganization and dynamicity of K16.
The opposing distinct footpad phenotypes occurring in TOC and
irhom2 / imply that the interaction between iRHOM2 and
K16 plays a role in the epidermal response to physical stress. To
investigate this, wild-type (WT) or TOC iRHOM2-GFP were
overexpressed in HaCaT keratinocytes. Fluorescent microscopy
showed that the K16 ﬁlament network was relatively unchanged
in WT-iRHOM2-GFP cells; however, in cells overexpressing TOC
mutant-iRHOM2 GFP, K16 showed subtle perinuclear redis-
tribution (Fig. 4a). To recapitulate mechanical footpad stress
in vitro, CTRL and TOC keratinocytes were cultured in mono-
layer on ﬂexible membranes and subjected to 4 h of oscillating
mechanical stress using the Flexcell system30. Both CTRL and
TOC cells showed induction of K16 and perinuclear distribution
of the ﬁlament network. This was more pronounced in TOC
cells, which demonstrated signiﬁcantly increased perinuclear
localization of K16 before stress (Fig. 4b,c). In situ iRHOM2-K16
PLA of stressed cells demonstrated an intense perinuclear signal,
implicating this interaction in K16 ﬁlament reorganization
(Supplementary Fig. 3b).
K6 anchors K16 to desmosomal adhesion junctions at the cell
surface membrane by direct interaction with desmoplakin,
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resulting in a branch-like ﬁlament network, which provides
structural support31,32. Overexpression of either WT or
Mut-iRHOM2-GFP in HaCaT keratinocytes led to profound
downregulation of K6 (Supplementary Fig. 4a). Moreover, TOC
cells subjected to mechanical stress are unable to restore K6
expression, despite upregulation of K16 (Supplementary
Fig. 4b). It is therefore tempting to speculate that differential
downregulation of K6 in TOC by iRHOM2 releases K16 from
desmosomal adhesion structures and facilitates perinuclear
reorganization of K16.
Moreover, keratin ﬁlament cycling plays a role epithelial
migration and proliferation33,34. In mice, the absence of K6
results in almost doubled K16 ﬁlament turnover29. To see
whether this phenomenon occurred in TOC, we treated
keratinocytes with the protein phosphatase inhibitor okadaic
acid (OA) for 1 h, which disassembled keratin ﬁlaments into
cytoplasmic aggregates35. Four hours following treatment, CTRL
cells show limiting recovery, with few ﬁlaments reformed.
However, in TOC cells there is partial recovery. Twenty-
four hours following treatment with OA, TOC cells show
normalization of K16 ﬁlaments; however, in CTRL ﬁlaments
remain aggregated in the cytoplasm (Fig. 4c). K6 ﬁlament
turnover was also assessed in CTRL cells and did not appear to
show accelerated turnover. The low expression of K6 in TOC cells
prevented accurate assessment of turnover in these cells
(Supplementary Fig 4c). These data reveal that the differential
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regulation of K16 and K6 in TOC keratinocytes contributes to
accelerated ﬁlament turnover and perinuclear re-organization of
the K16 ﬁlament network.
iRHOM2 regulates migration proliferation and inﬂammation.
TOC keratinocytes exhibit increased migration and proliferation
rates, similar to that observed in wound edge keratinocytes and
epithelial cancers4. As K16 is highly expressed at the wound
edge2,3 and also in several epithelial cancers9,14,15, we
hypothesized that iRHOM2-K16 could play a role in these
cellular events. iRHOM2 was depleted from CTRL and TOC cells
using shRNA. The robust downregulation of iRHOM2 and K16
in both cell lines was associated with reduced cell proliferation
(Fig. 5a). Ki67, a proliferation marker, was diminished in 3D
organotypics derived from shiRHOM2 TOC cells (Fig. 5b)
and also in the paws of irhom2 / mice (Fig. 5c). Reduced
proliferation and diminished K16 expression could explain the
thinner footpads seen in knockout mice.
Scratch-wound assays can demonstrate migration in mono-
layer36. We performed scratch-wound assays using CTRL and
TOC cells depleted of iRHOM2 and found that shiRHOM2
resulted in signiﬁcantly impaired wound closure as a result of
abrogated migration (Fig. 5d). Several substrates of ADAM17,
activated by iRHOM2, can contribute to migration and
proliferation23,24. It is possible that reduced ADAM17 shedding
could in part contribute to the changes in cell behaviour induced
by shiRHOM2. We demonstrated that depletion of iRHOM2 in
CTRL and TOC keratinocytes results in decreased ADAM17
maturation (Supplementary Fig. 5a) and, consequently, PMA
stimulation leads to dampened TNFa release from these cells
(Supplementary Fig. 5b). iRHOM2-ADAM17 regulation could
explain an unusual feature of the knockout mice phenotype.
Despite thinning of the palmoplantar epidermis and barely
detectable K16, these mice do not display the PPK-like features
observed in K16-null mice, which have a characteristic
inﬂammatory molecular signature19,37. It might be that
reduced ADAM17-mediated shedding of inﬂammatory
cytokines protects irhom2 / mice from developing an inﬂa-
mmatory keratoderma.
Discussion
K16 is a cytoskeletal protein with unique attributes contributing
to its expression in speciﬁc pathological and physiological
situations. It combines the distinct properties of mechanoresi-
lience, ﬂexibility and dynamic turnover, which are necessary in
the hyperproliferative ‘stressed’ stratiﬁed epithelia where it is
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Figure 5 | iRHOM2 regulates migration and proliferation. (a) Growth curves of cultured cells for Sh-Scr, Sh-IRHOM2 in CTRL and TOC keratinocytes
showing slower growth rates for Sh-iRHOM2 cells in both cell lines (mean of three independent experiments). (b) Confocal analysis showing the reduction
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expressed2,3, including at the wound edge, psoriasis, carcino-
genesis and the palmoplantar epidermis1,5,13,14. However, how
this particular keratin is regulated in response to cellular stress
has remained elusive. In the present study, using human and
mouse models, we report that iRHOM2 is a novel and unexpected
regulator of the cytoskeletal response to physical stress through its
interaction with K16. We demonstrate direct interaction between
iRHOM2 and K16, and show synchronicity between the
expression pattern of these two proteins; shRNA-mediated
knockdown of iRHOM2 in human keratinocytes or irhom2 /
in mouse paw skin is associated with depleted K16 and,
reciprocally, high iRHOM2 activity in TOC is associated with
increased K16.
Wound edge keratinocytes are poised to undergo proliferation
and migration and thus allow tissue regeneration38. K16 is rapidly
expressed in response to tissue injury and, ultrastructurally, has
been shown to adopt a perinuclear arrangement of ﬁlaments,
which proceeds the onset of migratory behaviour2. Further
studies have shown that this delocalization is linked to
fragmentation of rigid keratin ﬁlaments from the cell periphery,
thereby increasing cell plasticity, subsequently facilitating
proliferation, migration and invasion39,40. In TOC we observed
increased K16 expression and perinuclear distribution of the
ﬁlament network even in the absence of stress and this was
enhanced further by mechanical stretching. We propose that this
process is mediated by increased iRHOM2 activity. Our data
show increased binding between iRHOM2 and K16 in TOC and
this is also linked to downregulation of K16’s major binding
partner K6. It is tempting to speculate that this results because
iRHOM2 and K6 share the same interacting domain with K16,
Coil 1B. Intriguingly, we also observed, to a lesser extent,
downregulation of K6 at mRNA level; however, how this occurs
remains to be explored. Potentially, a negative feedback loop may
exist when K6 binding to K16 is reduced, thereby preventing
unstable K6 monomer accumulation in the cytoplasm. When K16
and K6 dimerize, the latter binds the complex to desmosomal
adhesions structures, stabilizing the intermediate ﬁlament
network31. Therefore, differential downregulation of K6 could
release K16 from desmosomes and allow perinuclear localization.
Moreover, K16 ﬁlament turnover is expedited in the absence of
K6 (ref. 29), further facilitating migration and proliferation.
Perinuclear localization of K16 and dynamic ﬁlament turnover
would in turn contribute to the increased proliferation and
migration in TOC. The combination of high K16 expression in
response to mechanical stress and increased cell turnover in the
presence of upregulated iRHOM2 activity provide a possible
explanation for the presence of PPK in TOC. This model could
also explain the diminished K16 expression and thinner footpads
in irhom2 / mice. Although wounded epithelia rapidly induce
both K6 and K16, perinuclear reorganization of K16 occurs
despite the presence of K6. This also raises the possibility that the
differential regulation of K6 and K16 occurring in TOC may be a
phenomenon linked to neoplasia in these cells.
As K16 is highly expressed in disease states such as epithelial
cancers and inﬂammatory dermatoses, there may be a broader
signiﬁcance for the role of iRHOM2 in the pathophysiology of
these disorders, which remains to be explored. The absence of
inﬂammation in the paws of irhom2 / mice in contrast to
K16-KO mice is noteworthy. K16-KO mice have previously been
shown to exhibit painful callous formation and activation of
inﬂammatory pathways and, histologically, an inﬂux of inﬂam-
matory cells such as macrophages are evident19,37. However,
irhom2 / mice exhibit thinned footpads without overt
inﬂammation. As ADAM17 is a further target of iRHOM2 in
keratinocytes and macrophages22,23,25, we suggest that its
downregulation in the paws of irhom2 / mice dampens the
development of an inﬂammatory PPK. This could point
to a hitherto unidentiﬁed role for ADAM17 in the development
of PPK-associated inﬂammation. Thus, pharmacological modula-
tion of iRHOM2 by targeting two stress-response proteins, K16
and ADAM17, could provide a speciﬁc therapeutic strategy
in the treatment of PPK’s, inﬂammatory epithelial disease and
neoplasia.
Methods
Antibodies. Details of antibodies used in the following experiments can be found
in the Supplementary Information (Supplementary Table 1).
Statistical analysis. Statistical analyses were carried out using the two-tailed
paired Student’s t-test, asterisks refer to signiﬁcance in graphs. *Pr0.05, **Pr0.01
and ***Pr0.001.
Yeast two-hybrid analysis. Yeast two-hybrid screening was performed by
Hybrigenics Services, S.A.S., Paris, France (http://www.hybrigenics-services.com).
The coding sequence for human iRHOM2 N terminus (aa 1–403; GenBank
accession number gi:306035188) was PCR ampliﬁed and cloned into pB29 as an
N-terminal fusion to LexA (N-iRHOM2-LexA-C). The construct was validated by
sequencing the insert and used as a bait to screen a random-primed human
Reconstituted Skin cDNA Library constructed into pP6. pB29 and pP6 derive from
the original pBTM116 (refs 41,42) and pGADGH43 plasmids, respectively. One
hundred and twelve million clones (13-fold the complexity of the library) were
screened using the mating approach with YHGX13 (Y187 ade2-101::loxP-kanMX-
loxP-mat) and L40DGal4 (mata) yeast strains as previously reported44. Twenty-
eight Hisþ colonies were selected by using a medium lacking tryptophan, leucine
and histidine. The prey fragments of the positive clones were ampliﬁed using PCR
and sequenced at both their 50- and 30-junctions. The resulting sequences were
used to identify the corresponding interacting protein fragments in the GenBank
database (NCBI) using an automated procedure. A conﬁdence score was attributed
to the interaction, taking into consideration the redundancy and independency of
the prey fragments and reading frames, and stop codons in overlapping fragments.
Second, taking into account the interactions found in all the previously performed
screens at Hybrigenics, using the same library. The scores have been shown to
correlate positively with the biological signiﬁcance of the interaction45,46
Cell culture. CTRL and TOC keratinocyte immortalized cell lines previously
described4 and produced from our laboratory were cultured in DMEM medium
(Sigma), which was supplemented with 1% penicillin/streptomycin, 10% FCS,
1% L-glutamine, 1% RMþ supplement (containing EGF). Cells were cultured in a
humidiﬁed incubator at 10% CO2, 37 C. HaCaT cells were cultured in DMEM
supplemented with 10% FCS, 1% L-glutamine and 1% penicillin/streptomycin, and
cultured in a humidiﬁed incubator at 10% CO2, 37 C.
All experiments were carried out on cells that had been passaged between 10
and 40 times post immortalization.
Western blotting. Cells were washed twice in PBS and then lysed using lysis
buffer (1M Tris, 2.5M NaCl, 10% Glycerol, 0.5M Glycerophosphate, 1% Tween-
20, 0.5% Nonidet P40, 1 EDTA-free Complete Protease Inhibitor tablet (Roche)
for 15min on ice. Protein extracts were separated on SDS 12% polyacrylamide gels
and transferred to a nitrocellulose transfer membrane. The blots were incubated
with speciﬁc primary and secondary antibodies and developed according to the
manufacturer’s instructions (ECL Immobilon, Millipore). Uncut blots are supplied
in Supplementary Fig. 6.
Immunostaining and image processing. Cells plated on cover slips or 5 mm tissue
sections were ﬁxed with either 4% paraformaldehyde (PFA) in PBS for 10min at
room temperature, or in ice cold Methanol-Acetone (50:50 mixture) at  20 C for
10min depending on the optimal method for detection of the primary antibodies.
The following steps were all carried out at room temperature. Cells were
permeabilized with 0.1% Triton X-100 for 10min if PFA ﬁxation was used, then
blocked with 5% goat serum for 1 h. Cells or tissue sections were incubated with
primary antibody diluted in 5% goat serum overnight at 4 C. The following day,
ﬁxed cells or tissue sections were washed in 3 5min in PBS, then incubated with
the appropriate Alexa Fluor (Life Technologies) ﬂuorescent secondary antibody for
1 h at room temperature. The secondary antibody was diluted 1:800 in 5% goat
serum. Cells or tissue sections were washed twice 3 5min in PBS, then incubated
in 4,6-diamidino-2-phenylindole nuclear stain (1:10,000), then washed twice for
10min each and ﬁnally mounted onto slides and imaged using the Zeiss 710
confocal microscope (Carl Zeiss).
The quantiﬁcation of perinuclear localization of CK16 ﬁlaments was based on
the method previously described47. CTRL and TOC cells were quantiﬁed in ImageJ
by drawing a line from the nuclear envelope across the plasma membrane using the
freehand tool and plotting the K16-associated ﬂuorescence signal along this line.
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K16 ﬁlament arrangements were classiﬁed as ‘perinuclear’ when all of the positive
ﬁlament signals (450% relative signal intensity, normalized to the maximum
ﬂuorescence of the speciﬁc cell) were found within 3 mm from the nuclear
membrane. Images were selected randomly and blindly subjected to this
quantiﬁcation. For the ﬁnal bar graph depicting the percentage of perinuclear cells,
90 images for each of CTRL and TOC from three independent experiments each
were quantiﬁed. Statistical analysis was performed using the unpaired Student’s
t-test.
Generation of 3D human skin equivalents. Following informed written consent,
human dermal ﬁbroblasts were isolated from skin biopsy of a patient undergoing
plastic surgery (abdominoplasty, sex and health status are unknown). This
procedure was performed under ethical approval of the East London Research
Ethics Committee. Fibroblasts were then embedded in 4mgml 1 collagen 1
matrices at a concentration of 250,000 cells per ml, to produce dermal equivalents.
After culturing these dermal equivalents for 24 h, keratinocytes were seeded on top
(30,000 cells per cm2) and kept in submerged culture for a further 24 h. Afterwards,
the human skin equivalents were lifted to the air–liquid interface and cultured until
day 14 with alternate daily media change, before being PFA-ﬁxed and parafﬁn-
embedded for processing.
Transfection of cell lines. RHBDF2 constructs were prepared by subcloning WT
RHBDF2 cDNA from Origene clone SC122961 (Origene) into vector pEGFP-N3.
Mutant RHBDF2 constructs were prepared using the QuikChange II site-directed
mutagenesis kit (Agilent). Details of the primer sequences used to introduce the
mutation are available in the Supplementary Information (Supplementary Fig. 8).
N terminus RHBDF2 construct was prepared by cloning WT RHBDF2-
N-terminal domain into vector pEGFP-N3. The plasmid was prepared using
In-Fusion HD Cloning kit (Clontech Laboratories, Takara). N terminus RHBDF2
constructs were a generous gift from Professor M. Freeman
HaCaT cells were grown on coverslips and plated at a density of 2 105 cells
per well of a six-well plate. Transfection was carried out after 24 h using. Fugene 6
(Roche). The cell culture medium was changed the next day. Cells were ﬁxed and
immunostained 48 h following transfection.
Co-immunoprecipitation. Cells were grown to conﬂuence in 10 cm plates. Plates
were washed twice on ice in ice-cold PBS and then lysis buffer was added with a
protease inhibitor cocktail (Roche). Lysates collected after 10min and pre-cleared
by centrifugation at 13,000G for 10min at 4 C. The supernatant was removed
from the debris pellet and transferred to a clean tube. Protein concentration was
calculated using the Bradford Protein Assay system (Bio-Rad). Fifty microlitres of
Dynabeads (Thermo) were prepared according to manufacturer’s instructions.
Antibodies (2–4 mg) were bound to the beads by incubation at room temperature
with rotation for 30min. Species matched IgG (Rabbit IgG sc-2027, Mouse IgG
sc-2025, Santa Cruz) were bound to beads as a control. Two milligram of protein
lysate was added to beads and incubated overnight at 4 C with rotation. The
following day, beads were washed three times for 5min on ice in 700 ml NP-40
wash buffer (50mM Tris pH 8.0, 150mM NaCl, 1mM EDTA and 1% NP40)
containing protease and phosphatase inhibitors (Roche) followed by separation on
a magnet. Beads were separated from antibody–protein complexes by boiling for
5min in 2 Laemelli buffer and the eluate separated by a magnet loaded onto a
gel for SDS–PAGE electrophoresis. The lysate was run alongside as an input for the
immunoprecipitation.
Flexcell mechanical stress assay. The Flexcell FX-4000 Tension System (Flexcell
International Corporation) is a computer-regulated bioreactor, which uses cyclical
vacuum pressure to apply strain to cells cultured on ﬂexible-bottomed culture
plates. This was used to subject speciﬁc cell monolayers to mechanical stress.
Control or TOC cells were grown to near conﬂuence on BioFlex six-well plates
coated with pronectin (Flexcell International Corporation), which contain a ﬂexible
membrane in each 35mm well. Each plate was placed over the Flexcell loading
station which contains six planar faced posts. Cells were subject to cyclic
mechanical stretch with a frequency of 5Hz and an elongation of amplitude
ranging from 10 to 13% based on prior optimization in keratinocytes. Cells were
stretched for either 0 h (unstretched control) and 4 h, and then prepared for
immunocytochemistry as described above.
Proximity ligation assay. PLA was performed using the Duolink in situ kit
(Sigma) according to the manufacturer’s instructions, cells were plated on cover-
slips or Bioﬂex six-well plates for cell stretching assay (above) and ﬁxed with
Methanol Acetone or PFA as described previously. Following ﬁxation, cells were
incubated in Duolink blocking solution for 30min at 37 C. Previously optimized
primary antibodies were diluted in Duolink Antibody diluent and added to cells,
which were incubated overnight at 4 C. The following day the cells were washed in
Duolink Wash buffer A 2 5min. The PLA plus and minus probes were diluted
1:5 in antibody diluent and added to the cells, which was incubated for 1hr at 37C.
The cells were washed in Duolink Wash buffer A 2 5min. The Ligation–Ligase
was prepared according to instructions and applied to cells for 30min at 37 C. The
cells were washed 2 2min in Duolink wash buffer A and the Duolink Ampliﬁ-
cation-Polymerase solution added and incubated for 100min at 37 C. The cells
were washed in Duolink wash buffer B for 2 10min and then mounted with
Duolink in situ mounting medium with 4,6-diamidino-2-phenylindole before
visualization with a Zeiss Confocal 710 microscope (Carl Zeiss). As a negative
control, no primary antibodies were applied. A further negative control was the use
of iRHOM1 instead of iRHOM2 primary antibody as a positive control, known
binding partners (such as K6 and K16) primary antibodies were applied.
Quantiﬁcation was performed using ImageJ software analysis programme
and analysed by Student’s paired t-test using GraphPad Prism (Graphpad,
San Diego, USA).
shRNA lentiviral particle transduction. shRNA lentiviral particle transduction
was used to silence RHBDF2 gene expression in human keratinocyte cell lines.
Lentiviral particles were purchased from Santa Cruz biotechnology (Santa
Cruz). The product contains a pool of concentrated transduction-ready viral
particles containing three target-speciﬁc constructs, which encode 19–25
nucleotide (plus hairpin) shRNA designed to knock down gene expression.
Cells were plated at 2 105 per well of a six-well plate, which resulted in
50–60% conﬂuence after 24 h. Cells were then treated with Polybrene (Santa Cruz),
a cation polymer used to increase the efﬁciency of infection of cells with the
retrovirus. Ten microlitres of Polybrene was added to the cells and incubated at
37 C for 20min. The Polybrene media was then removed and to this the lentiviral
particles (either RHBDF2 or negative scrambled shRNA sequence control) were
added. This was optimized using different concentrations of particles. The cells
were incubated overnight at 37 C in complete media. To select stably transfected
cells, Puromycin selection media was used. Cell lysates were obtained as described
above and analysed using SDS–PAGE electrophoresis and western blotting for
iRHOM2, to determine gene silencing.
Proliferation and cell migration assays. To measure proliferation, cells were
plated at a seeding density of 1 104 per well and harvested at 24 and 72 h, and
cell counts were performed using the Nucleocounter/Nucleocasette system
(ChemoMetec, Denmark). To measure migration, cells were seeded at equal
density on a six-well plate and grown for 24–48 h in complete media (as described
above) until a conﬂuent monolayer was achieved. Cells were treated with
Mitomycin C (400 ngml 1) to prevent proliferation. A vertical scratch was
performed using a 200 ml Gilson pipette tip. Cultures were washed three times in
PBS and incubated in media. Photographs were taken at 0, 18 and 24 h. Wounded
areas were measured using Image J software analysis. Results were analysed by
Student’s paired t-test using Graphpad Prism (Graphpad).
PMA treatment and ELISA. Cells were plated at equal density (3 105 per well)
on six-well plates and grown for 24 h in complete media. Cells were subsequently
treated with 250 ngml 1 PMA. Media was collected at time points (4 and 24 h) for
ELISA. Collected medium specimens were analysed for the TNFa using the DuoSet
ELISA kit (R&D Systems, Abingdon, UK) and compared with untreated controls.
In all cases, data are presented as mean ±s.e.m. Data shown represents the mean
of at least three separate experiments for each cell lines. Results were analysed by
Student’s paired t-test using GraphPad Prism (Graphpad).
OA treatment. CTRL and TOC keratinocytes were seeded on coverslips in 12-well
plates. After reaching the desired conﬂuence, cells were incubated in media
containing 1 mM OA (Sigma) for 1 h. The media was replaced without OA and cells
were ﬁxed for immunostaining as described above at time points following the
treatment (0, 4 and 24 h).
Animal experiments. All experiments involving mice followed the UK Animal
Welfare Act guidelines and approval of the UK Home Ofﬁce. irhom2 / mice
were generated as previously described22. All experiments were performed using
age and sex-matched littermates.
The fore and hind paw footpad epidermis from 20-week-old gender-matched
irhom2 / and irhom2þ /þ mice (n¼ 4 per genotype) were dissected and ﬁxed in
OCT on dry ice. Five micrometre sections were cut and mounted on slides. For
histopathological analyses, sections were ﬁxed in 4% PFA and stained with
haematoxylin/eosin according to standard protocols. Epidermal thickness was
measured using Image J software and analysed by students paired t-test (n¼ 4)
using GraphPad Prism (Graphpad).
Immunohistochemical staining was performed as previously described and
visualized using the Zeiss 710 Confocal Microscope (Carl Zeiss).
Quantitative real-time PCR. RNA was extracted from cultured cells using the
Qiagen RNeasy mini kit (Qiagen, Crawley, UK) following the manufacturer’s
instructions and converted to cDNA using Invitrogen SuperScript II reverse
transcriptase (Invitrogen, Grand Island, NY, USA). Quantitative real-time PCR
using TaqMan chemistry was performed on a Rotorgene Q thermocycler (Qiagen)
using primers against KRT6A, KRT16 and GAPDH, designed in-house, with target
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sequences across cDNA exon–exon boundaries. Details of the primer sequences
used are available in the Supplementary Information (Supplementary Table 2).
Specimens were assayed simultaneously for GAPDH and K16 or K6A using probes
labelled with different ﬂuorophores. The expression of all genes was quantiﬁed
relative to GAPDH using the DCt method48.
Data availability. The data that support the ﬁndings of this study are available
from the corresponding authors (A.C. and D.P.K.) upon reasonable request.
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